STAAR Surgical Company Income Statement

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 2, 2026	Dec '24 Dec 27, 2024	Dec '23 Dec 29, 2023	Dec '22 Dec 30, 2022	Dec '21 Dec 31, 2021
Revenue	239.44	313.9	322.42	284.39	230.47
Revenue Growth (YoY)	-23.72%	-2.64%	13.37%	23.39%	41.00%
Cost of Revenue	57.02	74.32	69.76	61.01	51.84
Gross Profit	182.42	239.58	252.65	223.38	178.64
Selling, General & Admin	188.31	206.88	184.08	143.6	111.44
Research & Development	40.06	45.32	40.48	35.98	33.86
Other Operating Expenses	45.77	-	-	-	-
Total Operating Expenses	274.13	252.19	224.55	179.58	145.3
Operating Income	-91.71	-12.61	28.1	43.8	33.34
Interest Income	4.59	6.42	7.06	3.25	0.98
Other Non-Operating Income (Expense)	4.86	-2.86	-1.46	-1.5	-3.01
Total Non-Operating Income (Expense)	9.45	3.56	5.6	1.75	-2.04
Pretax Income	-82.26	-9.05	33.7	45.55	31.3
Provision for Income Taxes	-1.82	11.16	12.35	5.89	3.79
Net Income	-80.45	-20.21	21.35	39.67	27.51
Net Income to Common	-80.45	-20.21	21.35	39.67	27.51
Net Income Growth	-	-	-46.18%	44.18%	365.26%
Shares Outstanding (Basic)	50	49	49	48	47
Shares Outstanding (Diluted)	50	49	49	49	49
Shares Change (YoY)	0.90%	-0.61%	0.10%	-0.15%	3.13%
EPS (Basic)	-1.62	-0.41	0.44	0.83	0.58
EPS (Diluted)	-1.62	-0.41	0.43	0.80	0.56
EPS Growth	-	-	-46.25%	42.86%	366.67%
Free Cash Flow	-40.05	-7.67	-3.59	17.61	30.32
Free Cash Flow Growth	-	-	-	-41.92%	141.63%
Free Cash Flow Per Share	-0.81	-0.16	-0.07	0.36	0.61
Gross Margin	76.19%	76.32%	78.36%	78.55%	77.51%
Operating Margin	-38.30%	-4.02%	8.71%	15.40%	14.47%
Profit Margin	-33.60%	-6.44%	6.62%	13.95%	11.94%
FCF Margin	-16.73%	-2.44%	-1.11%	6.19%	13.15%
EBITDA	-82.99	-5.72	33.22	48.31	36.98
EBITDA Margin	-34.66%	-1.82%	10.30%	16.99%	16.05%
EBIT	-91.71	-12.61	28.1	43.8	33.34
EBIT Margin	-38.30%	-4.02%	8.71%	15.40%	14.47%
Effective Tax Rate	2.21%	-123.24%	36.65%	12.92%	12.12%

Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q